Short Communication

Twin study: genotype-dependent epigenetic factors affecting free thyroxine levels in the normal range

Department of Clinical Laboratory & Biomedical Sciences, Osaka University Graduate School of Medicine, Yamadaoka 1–7, Suita, Osaka, 565-0871, Japan

Search for more papers by this author

Yuya Arakawa

Department of Clinical Laboratory & Biomedical Sciences, Osaka University Graduate School of Medicine, Yamadaoka 1–7, Suita, Osaka, 565-0871, Japan

Center for Twin Research, Osaka University Graduate School of Medicine, Yamadaoka 1–7, Suita, Osaka, 565-0871, Japan

Search for more papers by this author

Mika Hasegawa

Department of Clinical Laboratory & Biomedical Sciences, Osaka University Graduate School of Medicine, Yamadaoka 1–7, Suita, Osaka, 565-0871, Japan

Search for more papers by this author

Shiho Kato

Department of Clinical Laboratory & Biomedical Sciences, Osaka University Graduate School of Medicine, Yamadaoka 1–7, Suita, Osaka, 565-0871, Japan

Search for more papers by this author

Hinako Hashimoto

Department of Clinical Laboratory & Biomedical Sciences, Osaka University Graduate School of Medicine, Yamadaoka 1–7, Suita, Osaka, 565-0871, Japan

Search for more papers by this author

Saho Mori

Department of Clinical Laboratory & Biomedical Sciences, Osaka University Graduate School of Medicine, Yamadaoka 1–7, Suita, Osaka, 565-0871, Japan

Search for more papers by this author

Hiromichi Ueda

Department of Clinical Laboratory & Biomedical Sciences, Osaka University Graduate School of Medicine, Yamadaoka 1–7, Suita, Osaka, 565-0871, Japan

Search for more papers by this author

Mikio Watanabe

*Author for correspondence: Tel.: +81 06 6879 2592;

E-mail Address: nabe@sahs.med.osaka-u.ac.jp

https://orcid.org/0000-0001-5971-9296

Department of Clinical Laboratory & Biomedical Sciences, Osaka University Graduate School of Medicine, Yamadaoka 1–7, Suita, Osaka, 565-0871, Japan

Center for Twin Research, Osaka University Graduate School of Medicine, Yamadaoka 1–7, Suita, Osaka, 565-0871, Japan

Search for more papers by this author

Published Online:24 Jan 2024https://doi.org/10.2217/epi-2023-0372

View article

Abstract

Aim: To explore the clinical application of DNA methylation affecting thyroid function, we evaluated the association of DNA methylation with free thyroxine (FT4) and TSH measurements in monozygotic twins. Materials & methods: Discordant pairs for FT4 or TSH levels were examined for the relationship between the within-pair difference of each measurement and the DNA methylation levels using epigenome-wide association studies. The contribution of polymorphisms to the methylation sensitivity was also examined. Results: We found two CpG sites significantly associated with FT4 levels, and also some CpG sites showing significant differences in their methylation levels within FT4-discordant pairs depending on the polymorphism in EPHB2. Conclusion: The FT4 level may be associated with a combination of methylation and polymorphisms in the EPHB2 gene.

Graphical abstract

Keywords:

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

1. Visser WE, Friesema EC, Visser TJ. Minireview: thyroid hormone transporters: the knowns and the unknowns. Mol. Endocrinol. 25(1), 1–14 (2011).
Medline CASGoogle Scholar
2. Bianco AC, Kim BW. Deiodinases: implications of the local control of thyroid hormone action. J. Clin. Invest. 116(10), 2571–2579 (2006).
Medline CASGoogle Scholar
3. Hansen PS, Brix TH, Sørensen TI, Kyvik KO, Hegedüs L. Major genetic influence on the regulation of the pituitary–thyroid axis: a study of healthy Danish twins. J. Clin. Endocrinol. Metab. 89(3), 1181–1187 (2004). • Twin study on heritability of serum TSH and free thyroxine (FT4) levels.
Medline CASGoogle Scholar
4. Panicker V, Wilson SG, Spector TD et al. Heritability of serum TSH, free T4 and free T3 concentrations: a study of a large UK twin cohort. Clin. Endocrinol. 68(4), 652–659 (2008).
Medline CASGoogle Scholar
5. Kuś A, Chaker L, Teumer A, Peeters RP, Medici M. The genetic basis of thyroid function: novel findings and new approaches. J. Clin. Endocrinol. Metab. 105(6), doi: 10.1210/clinem/dgz225 (2020). • Genome-wide association study identifying genes affecting serum TSH and FT4 levels.
Google Scholar
6. Smith ZD, Meissner A. DNA methylation: roles in mammalian development. Nat. Rev. Genet. 14(3), 204–220 (2013).
Medline CASGoogle Scholar
7. Kulis M, Esteller M. DNA methylation and cancer. Adv. Genet. 70, 27–56 (2010).
MedlineGoogle Scholar
8. Feil R, Fraga MF. Epigenetics and the environment: emerging patterns and implications. Nat. Rev. Genet. 13(2), 97–109 (2012).
Medline CASGoogle Scholar
9. Pan Y, Liu G, Zhou F, Su B, Li Y. DNA methylation profiles in cancer diagnosis and therapeutics. Clin. Exp. Med. 18(1), 1–14 (2018).
Medline CASGoogle Scholar
10. Honda C, Watanabe M, Tomizawa R, Sakai N. Update on Osaka University Twin Registry: an overview of multidisciplinary research resources and Biobank at Osaka University Center for Twin Research. Twin Res. Hum. Genet. 22(6), 597–601 (2019). • An overview of the Osaka University Twin Registry, which manages the twin samples used in this study.
MedlineGoogle Scholar
11. Jones MJ, Islam SA, Edgar RD, Kobor MS. Adjusting for cell type composition in DNA methylation data using a regression-based approach. Methods Mol. Biol. 1589, 99–106 (2017).
Medline CASGoogle Scholar
12. Reinius LE, Acevedo N, Joerink M et al. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLOS ONE 7(7), e41361 (2012).
Medline CASGoogle Scholar
13. Taniguchi J, Masuda T, Iwatani Y et al. Rigorous evaluation of genetic and epigenetic effects on clinical laboratory measurements using Japanese monozygotic twins. Clin. Genet. 105(2), 159–172 (2023).
MedlineGoogle Scholar
14. Bottani M, Aarsand AK, Banfi G et al. European Biological Variation Study (EuBIVAS): within- and between-subject biological variation estimates for serum thyroid biomarkers based on weekly samplings from 91 healthy participants. Clin. Chem. Lab. Med. 60(4), 523–532 (2022).
Medline CASGoogle Scholar
15. Popovic M, Matana A, Torlak V et al. Genome-wide meta-analysis identifies novel loci associated with free triiodothyronine and thyroid-stimulating hormone. J. Endocrinol. Invest. 42(10), 1171–1180 (2019). •• Genome-wide association study revealing that EPHB2 affects serum free triiodothyronine and FT4 levels.
Medline CASGoogle Scholar
16. Pasquale EB. The Eph family of receptors. Curr. Opin. Cell Biol. 9(5), 608–615 (1997).
Medline CASGoogle Scholar
17. Drescher U. The Eph family in the patterning of neural development. Curr. Biol. 7(12), R799–807 (1997).
Medline CASGoogle Scholar
18. Brückner K, Klein R. Signaling by Eph receptors and their ephrin ligands. Curr. Opin. Neurobiol. 8(3), 375–382 (1998).
MedlineGoogle Scholar
19. O'leary DD, Wilkinson DG. Eph receptors and ephrins in neural development. Curr. Opin. Neurobiol. 9(1), 65–73 (1999).
MedlineGoogle Scholar
20. Park I, Lee HS. EphB/ephrinB signaling in cell adhesion and migration. Mol. Cells 38(1), 14–19 (2015). • An overview of the intracellular signaling and functions mediated by the EPH receptor encoded by the EPHB2 gene.
MedlineGoogle Scholar
21. Wohlfahrt JG, Karagiannidis C, Kunzmann S et al. Ephrin-A1 suppresses Th2 cell activation and provides a regulatory link to lung epithelial cells. J. Immunol. 172(2), 843–850 (2004).
Medline CASGoogle Scholar
22. Kawano H, Katayama Y, Minagawa K, Shimoyama M, Henkemeyer M, Matsui T. A novel feedback mechanism by ephrin-B1/B2 in T-cell activation involves a concentration-dependent switch from costimulation to inhibition. Eur. J. Immunol. 42(6), 1562–1572 (2012).
Medline CASGoogle Scholar
23. Nguyen TM, Arthur A, Hayball JD, Gronthos S. EphB and ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells. Stem Cells Dev. 22(20), 2751–2764 (2013).
Medline CASGoogle Scholar
24. Hodkinson CF, Simpson EE, Beattie JH et al. Preliminary evidence of immune function modulation by thyroid hormones in healthy men and women aged 55–70 years. J. Endocrinol. 202(1), 55–63 (2009).
Medline CASGoogle Scholar
25. Blazev R, Carl CS, Ng YK et al. Phosphoproteomics of three exercise modalities identifies canonical signaling and C18ORF25 as an AMPK substrate regulating skeletal muscle function. Cell Metab. 34(10), 1561–1577.e1569 (2022). • Analysis of the function of the C9ORF25 gene using knockout mice.
Medline CASGoogle Scholar
26. Pasquini LA, Marta CB, Adamo AM, Pasquini JM, Soto EF. Relationship between the ubiquitin-dependent pathway and apoptosis in different cells of the central nervous system: effect of thyroid hormones. Neurochem. Res. 25(5), 627–635 (2000).
Medline CASGoogle Scholar
27. Barbi J, Pardoll DM, Pan F. Ubiquitin-dependent regulation of Foxp3 and Treg function. Immunol. Rev. 266(1), 27–45 (2015).
Medline CASGoogle Scholar
28. Harbour JW, Luo RX, Dei Santi A, Postigo AA, Dean DC. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98(6), 859–869 (1999).
Medline CASGoogle Scholar
29. Xie B, Tan G, Ren J et al. RB1 is an immune-related prognostic biomarker for ovarian cancer. Front. Oncol. 12, 830908 (2022).
Medline CASGoogle Scholar
30. Lagou V, Garcia-Perez JE, Smets I et al. Genetic architecture of adaptive immune system identifies key immune regulators. Cell Rep. 25(3), 798–810.e796 (2018).
Medline CASGoogle Scholar
31. Zhang Y, Li Z, Chen M et al. lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer. Breast Cancer 27(4), 573–585 (2020).
MedlineGoogle Scholar
32. Ha H, Debnath B, Neamati N. Role of the CXCL8–CXCR1/2 axis in cancer and inflammatory diseases. Theranostics 7(6), 1543–1588 (2017).
Medline CASGoogle Scholar
33. Cui S, Qiao L, Yu S et al. The antagonist of CXCR1 and CXCR2 protects db/db mice from metabolic diseases through modulating inflammation. Am. J. Physiol. Endocrinol. Metab. 317(6), E1205–e1217 (2019).
Medline CASGoogle Scholar
34. Li L, Yee C, Beavo JA. CD3- and CD28-dependent induction of PDE7 required for T cell activation. Science 283(5403), 848–851 (1999).
Medline CASGoogle Scholar
35. Dubiel W, Chaithongyot S, Dubiel D, Naumann M. The COP9 signalosome: a multi-DUB complex. Biomolecules 10(7), (2020).
MedlineGoogle Scholar
36. Tomer Y, Hasham A, Davies TF et al. Fine mapping of loci linked to autoimmune thyroid disease identifies novel susceptibility genes. J. Clin. Endocrinol. Metab. 98(1), E144–152 (2013).
Medline CASGoogle Scholar
37. Lafontaine N, Campbell PJ, Castillo-Fernandez JE et al. Epigenome-wide association study of thyroid function traits identifies novel associations of fT3 With KLF9 and DOT1L. J. Clin. Endocrinol. Metab. 106(5), e2191–e2202 (2021).
MedlineGoogle Scholar
38. Weihs A, Chaker L, Martin TC et al. Epigenome-wide association study reveals CpG sites associated with thyroid function and regulatory effects on KLF9. Thyroid 33(3), 301–311 (2023).
Medline CASGoogle Scholar
39. International Hapmap C. The International HapMap Project. Nature 426(6968), 789–796 (2003).
MedlineGoogle Scholar

Vol. 16, No. 3

Supplemental Materials

Metrics

Downloaded 27 times

History

Received 23 October 2023

Accepted 9 January 2024

Published online 24 January 2024

Published in print February 2024

Information

Keywords

Supplementary data

To view the supplementary data that accompany this paper please visit the journal website at: www.futuremedicine.com/doi/suppl/10.2217/epi-2023-0372

Author contributions

Study conception and design were performed by S Yoshioka and M Watanabe; data collection was performed by M Watanabe, Y Arakawa and the Osaka Twin Research Group; statistical analysis was performed by S Yoshioka; analysis and interpretation of results were performed by M Watanabe, M Hasegawa, S Kato, H Hashimoto and S Mori; drafting of the article was performed by S Yoshioka, H Ueda and Y Arakawa; and supervision was provided by M Watanabe. All authors reviewed the results and edited and approved the final version of the manuscript.

Acknowledgments

The authors extend their appreciation to the Specially Appointed Researcher Kanako Akada (Center for Twin Research at Osaka University Graduate School of Medicine). The authors are also grateful to Beckman Coulter, Inc. (Tokyo, Japan) for their collaborative work.

Financial disclosure

The study was supported by JSPS KAKENHI (grant no. A19H040480) and University Grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Competing interests disclosure

The authors have no competing interests or relevant affiliations with any organization or entity with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Writing disclosure

Language editing services were provided by Elsevier and were funded by JSPS KAKENHI (grant no. A19H040480).

Ethical conduct of research

In this study, written informed consent was obtained from all participants, and the study protocol was approved by the Ethics Committee of Osaka University (nos. 696 and 10209). The study was performed in accordance with the Declaration of Helsinki.

PDF download